Sei Investments CO Anavex Life Sciences Corp. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$16.82 - $25.75 $1.17 Million - $1.79 Million	-69,645 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$10.16 - $28.86 $707,593 - $2.01 Million	69,645 New	69,645 $1.6 Million
Q3 2018 Nov 08, 2018	SELL	$2.23 - $3.82 $1,233 - $2,112	-553 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$2.08 - $4.26 $1,150 - $2,355	553 New	553 $1,000

152

26.5M

674K

811K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $443M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.